A full-year 2024 trading update for Arecor Therapeutics shows revenue was up to £5.1million (2023: £4.6m) while cash and cash ...

Amphastar's intranasal glucagon dry powder, Baqsimi, and Novo Nordisk’s dasiglucagon auto-injector, Zegalogue, compete with Gvoke. McCulloch said he had yet to see the rivals make a big ...

2019 The FDA accepts for review Xeris Pharmaceuticals ' (XERS -0.3%) marketing application seeking approval for a ready-to-use, room temperature-stable liquid glucagon auto-injector ...

Inc. to return the rights to Ogluo®, the ready to-use glucagon auto-injector pen for severe hypoglycaemia. Tetris Pharma delivered product sales of £3.4 million in 2024 (2023: £2.9 million).

Inc. to return the rights to Ogluo®, the ready to-use glucagon auto-injector pen for severe hypoglycaemia. Tetris Pharma delivered product sales of £3.4 million in 2024 (2023: £2.9 million).

Share on Pinterest Zepbound is a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide ... dose vial rather than as an auto-injector pen, also called a Zepbound pen.

Glucagon-like peptide 1 receptor agonists ... They are prescribed as auto-injector pens. You give yourself a shot either in the abdomen, thigh, or upper arm. One of the main differences between ...

VK2735 is a dual agonist of the glucagon-like peptide 1 ... We do plan to introduce an auto-injector in the Phase 3 program. So we would anticipate the product to launch as an auto-injector.

One of the therapeutic drugs for T2DM, dipeptidyl peptidase-4 (DPP-4) inhibitor, suppresses the degradation of incretins, glucagon-like peptides and ... improved in AD patients with intranasal insulin ...

Reasons to buy Viking Therapeutics now It's hard to overstate the commercial success of drugs that reduce appetites by acting on glucagon-like ... of semaglutide, the injection Novo Nordisk ...